| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |